Phase 3 Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 18 and 65 years old (inclusive), of any sex
- People with a Body Mass Index (a measure of body weight relative to height) above 18 and below 40
- People where plaque psoriasis covers at least 10% of the body surface area
- People with a PASI score of 12 or higher (a standard medical scoring tool used to measure how severe psoriasis is — confirm exact score with trial site)
- People with a PGA score of 3 or higher (another standard scale doctors use to rate psoriasis severity — confirm with trial site)
- People who have been diagnosed with moderate-to-severe plaque psoriasis
Who may not be able to join:
- People who have been diagnosed with certain other forms of psoriasis, specifically: erythrodermic psoriasis (where redness covers most of the body), generalised pustular psoriasis (von Zumbusch type, involving widespread pus-filled spots), guttate psoriasis (small drop-shaped patches), or palmoplantar psoriasis (affecting the palms and soles)
- People who have had an allergic reaction to the study drug in the past, or who are known to have a significant sensitivity to it
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 202-734-3400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and tolerability of ponesimod as measured by reporting of adverse events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.